Vol.98,No.1,1981 January
BIOCHEMICAL
AND
BIOPHYSICAL
RESEARCH
COMMUNICATIONS Pages
15,1981
INHIBITION
OF EPINEPHRINE-INDUCED DERIVATIVE OF WHEAT Pankaj
From
Received
Ganguly
and
PLATELET AGGREGATION GERM AGGLUTININ Nancy
G.
BY A
Fossett
the Department of Hematology, St. Jude Hospital and Department of Biochemistry, Tennessee, Memphis, Tennessee
November
297-302
Children's University 38101
Research of
29,198O SUMMARY
A nonagglutinating derivative of wheat germ agglutinin has been prepared The and used as a probe to explore the initial events in platelet activation. lectin derivative had no effect on platelet aggregation by adenosine diphosphate, collagen, ristocetin, wheat germ agglutinin or trypsin but aggregation Unlike thrombin, the induced by epinephrine or thrombin was inhibited. inhibition of aggregation by the derivative could not be overcome by The derivative did not affect increasing the concentration of epinephrine. the binding of [3H]dihydroergocryptine to platelets. A 74,000 dalton protein isolated from platelet membranes by lectin affinity chromatography strongly by thrombin but not by epinephrine. The inhibited platelet activation receptors for thrombin and for epinephrine on platelets are different but they are closely linked.
Human with
a
initial to
platelets
number step
of in
specific
of
available
on
the
primarily
between
associated
with
but
by
of
a
rapidity
host
of
which
other
To germ
from
agglutinin
aggregation was
297
is
This
paucity
little
our
these
initial
events,
affected
does
not
This
lectin
while (4).
broad
inability
metabolic
thrombin
and
information
general
capacity.
ligands
information of
and
which
The
the
the
by not
these
While
there
2).
aggregation
(3).
(WGA)
binding
of cell
interactions
explore
cell
to
incubated
(1,
binding
events
involved.
events
agents
be
known,
the
when
catecholamines
leads
of are
of
platelet
reaction
to
series
considerable
inhibited
believed
aggregation
wheat
and
surface
activation.
retains
strongly
cell
ligand-specific cell
a secretion
interactions
the
a derivative
platelets
induced
platelet
to
is
complicated
molecular
due
distinguish
tive
a
the
undergo thrombin
activation on
following
and including
platelet
characteristics
prepared
agents
receptors
secretion
is
aggregate
Further
to changes we
have
stimulate derivaaggregation studies
0006-291X/81/010297-06$01.00/0 Copyrighf 0 1981 by Academc Press, Inc. All rights of reproduction in any form reserved.
Voi.98,
No.1,1981
revealed
that
giving
rise
BIOCHEMICAL
the to the
epinephrine
and
platelet
derivative
receptors
be closely
can
possibility
thrombin for
AND
BIOPHYSICAL
block
that
platelet
there
We present
and for
COMMUNICATIONS
aggregation
may be a single
on platelets. epinephrine
RESEARCH
data
thrombin
are
by epinephrine receptor
which
for
both
show that
different
but
the
they
may
coupled. MATERIALS
AND METHODS
Blood was collected from healthy volunteers in plastic syringes utilizing 0.1 volume of 3.8% sodium citrate as anticoagulant. The red cells were removed by low speed centrifugation and the platelets were isolated as described (5). Wheat germ agglutinin (WGA) was purchased from U.S. Biochemicals (Cleveland, Ohio). Data on its purity and interaction characteristics with platelets have been published (6-8). The WGA derivative was prepared by treating the lectin in 65% formic acid with excess CNBr for 20 hr Epinephrine (1 mg/ml) in 0.15 M NaCl was purchased from Parke Davis (4). (Detroit, Michigan). Platelet aggregation was measured in a dual channel aggregometer (Payton, Buffalo, New York) (7). The experimental sample was analyzed in one channel while a control was run in the other. The amounts of stimulants shown are final concentrations. To measure secretion, platelets were loaded with [14C]serotonin (59 mCi/mmol, Amersham, Arlington Heights, Illinois) and aggregation experiments were carried out as above. Five min after the addition of the stimulant, 0.1 ml of 10% formaldehyde was added to the platelet suspension. The samples were centrifuged and the radioactivity in an aliquot of the supernatant was measured and expressed as percent of appropriate controls (7). in phosphate-buffered saline (PBS) was first Platelets suspended incubated for 10 min at room temperature with different amounts of the WGA derivative and then for another 15 min with a constant amount of C3Hldihydroergocryptine (DHEC, 24 Ci/mmol, New England Nuclear, Boston, Massachusetts) in the dark. The platelet-bound DHEC was separated from free DHEC by filtration through 1.2 u millipore filters under reduced pressure (9). The tubes and filters were then washed with 5 ml of buffer. The filters were dried and counted in a Packard liquid scintillation counter with an efficiency of 45%. Nonspecific binding was determined in the presence of 100 fold excess phentolamine (Ciba, Summit, N.J.) (10). RESULTS AND DISCUSSION Incubation
of
aggregation.
wave after
aggregation.
The
induced
by epinephrine
trypsin
was
inhibition perturbation
with
The aggregation
a secondary to
platelets
not of
There
some delay. WGA derivative
affected
platelets
amounts
of
was characterized
while
under
the
by
by a primary
inhibited
by collagen, same conditions
aggregation the
epinephrine
was no detectable
strongly
aggregation
epinephrine-induced of
small
WGA derivative.
was
led
to
cell
wave followed shape
change
platelet
by prior
aggregation
ADP, WGA, ristocetin (Fig.
1)
(4).
not
due
to
The
inhibitory
Thus,
and the
a nonspecific effect
was
Vol.98,No.1,1981
BIOCHEMICAL
AND
BIOPHYSICAL
RESEARCH
COMMUNICATIONS
b.
1
,
I
1
1 MINUTE
1 MINUTE
A Fiq. 1. (A) Inhibition of epinephrine-induced aggregation of human platelets in plasma (3 x 108/ml) by the derivative of wheat qerm aqqlutinin. Pattern (a). shows the control while in patterns (b) and -(c) piatelets were preincubated with 100 pg/ml and 150 pg/ml of the lectin derivative respectively. Aggregation was initiated with 10 pg of epinephrine added at the arrow to a final volume of 0.5 ml of the platelet suspension. (B) Lack of effect of the lectin derivative on ADP-induced platelet aggregation. This experiment was done as in (A) by adding 1 x 10 5 M ADP at the arrow. Pattern (a) shows the buffer control while in pattern (b) the sample was preincubated with 100 pg/ml of the derivative.
more
on
prominent
aggregation
by
platelets the
we
conditions from
serotonin
release
overcome One
with this on
is
not
the
epinephrine-induced phenomenon
that
of
of
or
(c)
of
only the
the C3H]OHEC to
its of
to
2).
299
the sample
Under release
(a)
release.
different
the
platelet
receptor
of
showed This
inhibi-
could
not
derivative
activation on
87%
be
that
WGA the is
by
platelets.
concentrations The
suggesting by
platelets.
WGA derivative
platelets.
platelets
aggregation
4%
blocks
to
effect
1,
from
epinephrine.
WGA derivative binding
from
Fig.
secondary
secreted
aggregation,
had by
Since
materials
serotonin
In
secretion
the
DHEC
with
blocked
(b)
of
aggregation.
inhibited.
measured
platelet (Fig.
release
for
binding
binding
associated
concentration
epinephrine
the
been
or
the
primary
derivative
sample
we
on
also
aggregation
point,
derivative affect
was
increasing
than
the WGA
while
possibility
competing explore
the
platelets
platelet by
has
measured
when
serotonin
of
secondary
epinephrine
(ll),
tion
the
To of
derivative inhibition a post-binding
the did of
Vol. 98, No. 1,198l
BIOCHEMICAL
AND
BIOPHYSICAL
RESEARCH
COMMUNICATIONS
6-
I0
2
I 6
4
I 8
I IO
, 12 DERIVATIVE
LECTIN
I I 14 16 pg/ml
I I8
I 20
Fiq. 2. Effect of increasing concentration of the derivative of wheat germ agglutinin on the binding of [3H]dihydroergocryptine to platelets. Platelets in PBS were first incubated with different amounts of the lectin derivative for 10 min at room temperature and then a constant amount (1 nM) of DHEC was added. The amount of DHEC bound to platelets was determined after 15 min at room temperature by millipore filtration.
The
above
derivative two
results
are
different
different of
of
isolated
glycoprotein
tested.
Similar
the
glycoprotein
The
glycoprotein
conditions
be
platelet
did
not
of
and
different
caused
led
aggregation
the
The by
collagen
by
epinephrine
only
by
on
solubi-
isolation effect
of of
several
ADP,
induced
WGA or
of
to
(4).
by
the
molecules
chromatography
induced
aggregation
platelet
two
74,000
aggregation
affect
epinephrine
WGA derivative
aggregation
blocked
on
weight
platelet
for
Affinity
the
molecular
to
located
molecule.
utilizing
on
receptors
this
agents or
was
trypsin, (Fig.
thrombin
3).
under
these
(4).
adrenergic,
receptors
p-adrenergic
catecholamines
in
evidence
the
the
may same
apparent
Catecholamine
through
the
membranes
a glycoprotein
that
which
sites
/ platelet
lized
indicate
that
or
aggregation
receptor
prepared
a
explore
the
cells
by
although
the unclear
derivative events
in
to
response.
platelets
remained
have
according
cellular
human
receptor
nonagglutinating initial
a of
have
different
dopaminergic
elucidating
an or-adrenergic platelet
on
of
platelet
classified
the
potency
There
is
catecholamines identity (11,
WGA activation
300
been
and 12, and
used (4).
of
exact
indirect mediated
properties
We it
be
have as
This
a
CY-
various
some may
13).
as
of recently
probe derivative
to
BIOCHEMICAL
Vol.98,No.1,1981
AND
BIOPHYSICAL
RESEARCH
COMMUNICATIONS
1 MINUTE
I 1 1 MINUTE
B
A
Fiq. 3. (A) Lack of on epinephrine-induced Pattern (a) is the incubated for 10 min Aggregation protein. arrow to a final platelet aggregation ment was done as in the arrow. Pattern was first incubated ture before addition
blocked
platelet
induced
by
on
number
to
in
exerts
a
action study
through
a
the
isolated
are
by
two
blocked
effect
on
platelet
aggregation
protein
concentration.
Thus,
tion leads
by
epinephrine to
signal
by generation.
it
only
agent
the
observations
301
derivative inter-
results
unlike
platelet
of
the
at
inhibits
processing suggest
could
and
(b) but
ten
fold
platelet of
the
derivative
a
this
thrombin,
activation
even
derivative
with
the
The
by
act
specificity
epinephrine-platelet
(a)
was
may
of
concentration
epinephrine
lectin
These
that
thrombin.
thrombin-induced
study
epinephrine
unlikely
epinephrine
by
aggregation
This
degree
aggregation
the
interfering
and
differences:
platelet
the
(4).
high
on
except
important
increasing
glycoprotein
The
effect
while
affected thrombin
made
other
epinephrine
not
whether
reaction
any
by
receptor.
epinephrine-induced
reversed
was
hypothesis
inhibitory
there
and
agents
inhibition
that
thrombin
single
affecting
of be
other
the
without
inhibition not
of
nonspecific
show
by
explore
platelets
observed
of the isolated receptor for the lectin derivative aggregation of platelets in plasma (3 x lOa/ml). buffer control while in pattern (b) the ligand was first at room temperature with 4 pg/ml of the 74,000 dalton was initiated with 10 ug of epinephrine added at the volume of 0.5 ml. (13) Inhibition of thrombin-induced by the 74,000 dalton protein of platelets. This experi(A) but with 50 mU (1 nM) of thrombin which was added at (a) is the buffer control while in (b) the thrombin sample with 1.2 pg/ml of the protein for 10 min at room temperato the platelets.
stimulation
a
undertaken
effect
the had higher
aggrega-
the
receptor
that
the
which thrombin
no
BIOCHEMICAL
Vol.98,No.1,1981
receptor
and
closely
linked.
epinephrine
AND
receptor
on
BIOPHYSICAL
platelets
are
RESEARCH
COMMUNICATIONS
different
but
they
may
be
and
by
ACKNOWLEDGMENTS This
study
was
supported
by
grants
HL
16720
and
CA 21765
from
NIH
ALSAC. REFERENCES
1.
2. 3. 2 6. 7.
O'Brien, J. R. (1963) Nature 200, 763-764. Sidhu, P., Sutherland, S. B., and Ganguly, P. (1979) Am. J. Physiol. H353-H358. Ganguly, P. (1974) Nature 247, 306-307. Ganguly, P., and Fossett, N. G. (1981) Blood, in press. Ganguly, P. (1972) J. Biol. Chem. 247, 1809-1816. Ganguly, P., and Fossett, N. G. (1979) Biochem. Biophys. Res. Commun. 1154-1160. and Sidhu, P. (1979) Biochim. Biophys. Ganguly, P., Fossett, N. G.,
237,
89, Acta
586, 574-583.
8. 9. 10. 11. 12. 13.
Ganguly, P., 261. Ganguly, P., Alexander, R. 61, 1136-1144. Mills, D. C. 195, 715-722. Grant, J. A., Rossi, E. C., 286-294.
and
Fossett,
N.
G.
and H.,
Sonnichsen, Cooper,
B.,
W. J. (1976) and Handin,
B.,
Robb,
and Scrutton, Louis, G.,
I.
A., M. and
(1980)
and
Roberts,
C. (1979) Zeller, E.
302
Biochim.
Biophys.
Acta
Haematol. BI r. J. R. I. (1978) J. G.
C.
K.
256-
34, Clin.
291-301. Invest.
J.
Physiol.
(1968)
Nature 277, 659-661. A. (1979) J. Lab.
627,
Clin.
Med.
93,